JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
(2014) Blood — Vol. 124, n° 13, p. 2104-2115 (2014)
Files
pdfdocument.pdf
Restricted Access - Adobe PDF
- 631.35 KB
Details
- Authors
- Abstract
- Megakaryopoiesis is a 2-step differentiation process, regulated by thrombopoietin (TPO), on binding to its cognate receptor myeloproliferative leukemia (MPL). This receptor associates with intracytoplasmic tyrosine kinases, essentially janus kinase 2 (JAK2), which regulates MPL stability and cell-surface expression, and mediates TPO-induced signal transduction. We demonstrate that JAK2 and MPL mediate TPO-induced proliferation arrest and megakaryocytic differentiation of the human megakaryoblastic leukemia cell line UT7-MPL. A decrease in JAK2 or MPL protein expression, and JAK2 chemical inhibition, suppress this antiproliferative action of TPO. The expression of JAK2 and MPL, which progressively increases along normal human megakaryopoiesis, is decreased in platelets of patients diagnosed with JAK2- or MPL-mutated essential thrombocytemia and primary myelofibrosis, 2 myeloproliferative neoplasms in which megakaryocytes (MKs) proliferate excessively. Finally, low doses of JAK2 chemical inhibitors are shown to induce a paradoxical increase in MK production, both in vitro and in vivo. We propose that JAK2 and MPL expression levels regulate megakaryocytic proliferation vs differentiation in both normal and pathological conditions, and that JAK2 chemical inhibitors could promote a paradoxical thrombocytosis when used at suboptimal doses.
- Affiliations
Citations
Besancenot, R., Roos-Weil, D., Tonetti, C., Abdelouahab, H., Lacout, C., Pasquier, F., Willekens, C., Rameau, P., Lecluse, Y., Micol, J.-B., Constantinescu, S., Vainchenker, W., Solary, E., & Giraudier, S. (2014). JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation. Blood, 124(13), 2104-2115. https://doi.org/10.1182/blood-2014-03-559815 (Original work published 2014)